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TO THE EDITOR
Focal palmoplantar keratoderma (FPPK)
is a genetically heterogeneous pheno-
type characterized by the presence, on
the palms and soles, of circumscribed
calluses. These can be painful and are
usually the most prominent on areas
subject to mechanical stress (Kelsell
and Stevens, 1999). Recently, we
identified two patients with FPPK from
a three-generation Chinese family con-
sisting of 29 members (Supplementary
Figure S1 online). The proband
(Supplementary Figure S1 online, II-7)
was a 37-year-old male, who presented
with distinct hyperkeratosis lesions on
the palms and soles (Figure 1a and b).
His son (Supplementary Figure S1
online, III-7) also showed focal hyper-
keratosis on the fingers, palms, and toes
(Figure 1c–e). Besides the characteristic
hyperkeratosis, patients did not present
with any other abnormalities. To look
for the causative mutation, we con-
ducted whole-genome sequencing on
selected family members (Supplemen-
tary Figure S1 online). Samples used in
this study were obtained according
to the principles expressed in the
Declaration of Helsinki Princples and
were approved by the Institutional
Review Board from Guangdong Medical
Committee (GMA2012-01) and Western
Institutional Review Board (no. 13232).
All participants provided written
informed consent. A de novo dominant
mutation in the transient receptor
potential vanilloid 3 (TRPV3) protein
that resulted in a p.Gln580Pro
amino acid change was identified as
the causative mutation for our patients
(detailed description of sequence
analysis is in Supplementary Infor-
mation onilne). The mutation was
also confirmed by traditional Sanger
a b c
f g
h i
j k
l m
n o
d e
Figure 1. Clinical presentation and histological and Immunohistochemistry results. The proband (II-7)
showed large calluses on soles (a, b). The patient, III-7, presented less severe lesions on fingers, palms
(c, d), and toes (e). Histopathology study (sole, II-7) revealed prominent hyperkeratosis, thickened stratum
spinosum layer with reduced stratum granulosum, disadhesion of cells in the suprabasal layers, elongation
of rete ridges, and sparse lymphocyte infiltration in the dermis (f, g). The slide was stained with
hematoxylin-eosin and photographed at  40 (f). The yellowed box region was magnified at  100 (g).
Panels h–o show results for immunohistochemistry staining on transglutaminase 1 (h, i), filaggrins (j, k),
keratin 10 (KRT10; l, m), and KRT14 (n, o), with sections from normal skin and focal palmoplantar
keratoderma (sole, II-7) at  200. Scale bars¼ 100mm.
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sequencing (Supplementary Figure S2
online).
TRPV3 belongs to a large family of
calcium-permeable transient receptor
potential ion channel membrane
proteins that contain six transmemb-
rane domains (Nilius et al., 2014).
The Gln580 residue is located in a
conserved cytosolic region linking the
fourth and fifth transmembrane domains.
(Supplementary Figure S3 online). To
study the functional impact of this muta-
tion on TRPV3 activity, we trans-
fected HEK293T cells with wild-type
and Gln580 mutation TRPV3 clones
(Supplementary Figure S4a and S4b
online). Cells with Gln580Pro TRPV3
mutant showed an increased intra-
cellular Ca2þ concentration compared
with cells with wild-type TRPV3,
suggesting that the Gln580 mutation in
TRPV3 is a gain-of-function change
(Supplementary Figure S4c and S4d
online). This is further supported by the
finding that a pan TRPV antagonist,
ruthenium red, can reduce the escala-
tion of intracellular Ca2þ level induced
by TRPV3 mutant (Supplementary Figure
S5 online).
To understand the molecular changes
associated with the pathology, we com-
pared transcriptome and proteome of
involved and adjacent uninvolved skin
samples from sole (II-7) and palm (III-7)
of patients using microarray and iTRAQ
(isobaric tags for relative and absolute
quantitation). With iTRAQ, we identi-
fied 941 unique proteins and quantified
558 of them (Supplementary Table S1
online). The transcriptome and pro-
teome profiling results showed genes/
proteins that are known to be highly
expressed in the stratum granulosum
and stratum spinosum layers, such as
keratin 10 (KRT10), transglutaminases
(TGMs), and filaggrins (FLGs) were de-
creased in the involved skin compared
with the uninvolved areas (Figure 2a,
Supplementary Table S2 online). The
expression level changes of selected
mRNAs were also verified by quantita-
tive reverse-transcriptase in real-time
PCR (Supplementary Figure S6 online).
Immunohistochemistry results showed
weaker signals without clear stratum
granulosum layer staining with TGM1
(Figure 1h and i) and FLG (Figure 1j and
k) in patient sample compared with
regular skin. These findings are in agree-
ment with the decreased stratum granu-
losum layer and increased stratum
spinosum observed in histopathology
examination (Figure 1f and g). The
expression levels of desmocollin 1, des-
moglein 1, gap junction protein beta 2,
and E-cadherin that encode proteins
associated with gap junction, tight junc-
tion, and desmosomes were decreased
in FPPK involved skin samples
(Figure 2b), which is supported by
the disadhesion of cells in the supraba-
sal layers of the epidermis observed
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Figure 2. The effect of transient receptor potential vanilloid 3 mutation on the expression of genes related to keratinocyte differentiation and cell adhesion. The
expression level changes of genes that relate to cell adhesion and keratinocyte differentiation were shown in a. The gene identity is listed on the left and the patient
ID is listed at the bottom. The changes in gap junction, tight junction, and desmosome-associated genes in focal palmoplantar keratoderma (FPPK) are shown in b.
The identity of genes is listed on the left and the patient ID is indicated at the bottom. The expression level changes of several keratinocyte proliferation– and
differentiation–associated transcription factors are shown in c. The green circles indicate decreased expression levels in FPPK involved skin, whereas the red circle
represents increased levels.
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under histopathology examination
(Figure 1f and g).
Transcriptomic profiling results also
revealed changes in the levels of several
keratinocyte proliferation– and diffe-
rentiation–related transcription factors.
For example, the expression level of
MYC, a key transcription factor in reg-
ulating cell proliferation, was increased
in involved skin, whereas its antagonists
including MXD1 (MAX dimerization
protein 1), MXD3 (MAX dimerization
protein 3), MXI1 (MAX interactor 1,
dimerization protein), and OVOL1
(Ovo-like 1 protein) were decreased
(Rottmann and Luscher, 2006; Wells
et al., 2009). In addition, NOTCH1,
TP63 (tumor protein p63), ZNF750
(zinc finger protein 750), and KLF4
(Kruppel-like factor 4) that are involved
in keratinocyte differentiation were also
decreased in the FPPK involved skin
(Figure 2c; Nguyen et al., 2006; Chen
et al., 2008; Wells et al., 2009; Cohen
et al., 2012). This impairment of normal
keratinocyte proliferation and develop-
ment process is further supported by the
expression level changes of KRT10 and
KRT14, which are preferentially
expressed by keratinocytes located in
the spinosum and basal layers,
respectively (Figure 2a). Immunohisto-
chemistry revealed a broader layer of
KRT14-positive cells at the basal layer
and weaker KRT10-positive cells in
the spinosum layer in FPPK patients
(Figure 1l–o). At the pathway and bio-
logical process levels, cell differentia-
tion and skin barrier formation–related
activities, such as cell cycle and kerati-
nization, were enriched in downregu-
lated genes, whereas cell death–related
processes were associated with upregu-
lated genes in involved skin when com-
pared with adjacent uninvolved skin
samples (Supplementary Table S3
online). These results are consistent with
the observation of distinctly thickened
stratum spinosum layer with the reduc-
tion or absence of the stratum granulo-
sum in immunohistochemical and
histopathological examination. Combin-
ing the results of gene expression
profiling, pathway analysis and immu-
nohistochemistry suggest that the muta-
tion in TRPV3 disrupts the balance
of keratinocyte proliferation and differ-
entiation processes.
The epidermis contains highly differ-
entiated keratinocytes that replenish
and form the cornified layer, the outer
barrier of the skin. Proper TRPV3 activ-
ity is critical in skin development.
TRPV3-deficient mice display thermal
hyperalgesia, defects in skin barrier for-
mation, wavy hair, and a curly whisker
phenotype (Schneider et al., 2008;
Cheng et al., 2010; Radtke et al.,
2011). Recent reports on several muta-
tions in human TRPV3 involved in the
Olmsted syndrome (OS; Lin et al., 2012;
Danso-Abeam et al., 2013) further
support the importance of TRPV3
activity in keratinocytes development.
Compared with OS, our patients with
FPPK showed a mild clinical pre-
sentation, which might be caused by
different mutations leading to functional
differences in TRPV3. The finding that a
gain-of-function mutation in TRPV3
causes the clinical phenotype in our
patients opens the possibility of treating
TRPV3-associated FPPK or similar skin
conditions with TRPV3 antagonists.
Developing a TRPV3-specific inhibitor
is an active area of drug discovery for
treatment of itching or other sensations
(Salat et al., 2013), which may also
provide systematic or topical
treatments for patients with FPPK.
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